RAC 3.31% $1.61 race oncology ltd

Industry news, page-1843

  1. 19,075 Posts.
    lightbulb Created with Sketch. 5878
    Yes. The AML trial we are going to run is a pure anticancer trial. We could run dozens of trials similar to this is we felt it was in the interest of the RAC shareholders.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.